Xeris Biopharma Holdings, Inc.·4

Aug 9, 4:06 PM ET

Pieper Steven 4

4 · Xeris Biopharma Holdings, Inc. · Filed Aug 9, 2024

Insider Transaction Report

Form 4
Period: 2022-01-29
Pieper Steven
See Remarks
Transactions
  • Tax Payment

    Common Stock

    2022-07-28$1.43/sh9,767$13,9671,612,935 total
  • Tax Payment

    Common Stock

    2023-01-03$1.12/sh23,067$25,8351,589,868 total
  • Tax Payment

    Common Stock

    2023-01-29$1.26/sh3,590$4,5231,586,278 total
  • Tax Payment

    Common Stock

    2023-01-31$1.24/sh778$9651,585,500 total
  • Tax Payment

    Common Stock

    2023-07-28$2.53/sh10,200$25,8061,575,300 total
  • Tax Payment

    Common Stock

    2024-01-03$2.24/sh23,067$51,6701,552,233 total
  • Tax Payment

    Common Stock

    2024-01-29$2.66/sh4,379$11,6481,547,854 total
  • Tax Payment

    Common Stock

    2024-01-31$2.46/sh110,750$272,4451,437,104 total
  • Tax Payment

    Common Stock

    2024-07-28$2.61/sh14,767$38,5421,422,337 total
  • Tax Payment

    Common Stock

    2022-01-31$2.11/sh750$1,5831,622,702 total
  • Tax Payment

    Common Stock

    2022-01-29$2.11/sh3,460$7,3011,623,452 total
Footnotes (12)
  • [F1]This transaction is being reported late due to administrative oversight.
  • [F10]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2024.
  • [F11]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2024.
  • [F12]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of July 28, 2024.
  • [F2]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January, 29, 2022.
  • [F3]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2022.
  • [F4]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of July 28, 2022.
  • [F5]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2023.
  • [F6]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 29, 2023.
  • [F7]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 31, 2023.
  • [F8]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of July 28, 2023.
  • [F9]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of January 3, 2024.

Documents

1 file
  • 4
    wk-form4_1723234008.xmlPrimary

    FORM 4